ENTITY

Omeros Corp (OMER US)

1
Analysis
Health CareUnited States
Omeros Corporation is a biopharmaceutical company developing a pipeline of product candidates for use in orthopedics, rheumatology, urology, cardiovascular medicine, general surgery and pain management.
more
08 Jan 2025 22:12Issuer-paid

Biopharma Week in Review - January 6, 2025

On the obesity front, NVO’s CagriSema fell short of expectations, while the FDA reaffirmed LLY’s GLP-1 shortage resolution, bearing bad news for...

Logo
212 Views
Share
No more insights
x